Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 13635 | 760 | 44.1 | 87% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 392 | 16284 | LONG QT SYNDROME//BRUGADA SYNDROME//QT INTERVAL |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | OVARIAN SEX HORMONES | Author keyword | 4 | 67% | 1% | 4 |
| 2 | PARTNERSHIP WOMENS HLTH | Address | 4 | 75% | 0% | 3 |
| 3 | NOLL 106 | Address | 4 | 56% | 1% | 5 |
| 4 | CARDIAC PHEN | Address | 3 | 50% | 1% | 5 |
| 5 | GENDER MED | Address | 2 | 10% | 3% | 19 |
| 6 | BIOINFORMAT PHARMACOL | Address | 2 | 22% | 1% | 8 |
| 7 | CARDIAC MYOFILAMENT ACTIVATION | Author keyword | 1 | 100% | 0% | 2 |
| 8 | INBB OSILO SASSARI | Address | 1 | 100% | 0% | 2 |
| 9 | MED POLIKLIN 2 | Address | 1 | 50% | 0% | 2 |
| 10 | GENDER MED GIM | Address | 1 | 40% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ACUTE MYOCARDIAL PROTECTION | 8 | 75% | 1% | 6 |
| 2 | FEMALE GENDER | 7 | 30% | 3% | 20 |
| 3 | HEART RATE RELATION | 4 | 56% | 1% | 5 |
| 4 | CALCIUM HANDLING PROTEINS | 4 | 44% | 1% | 7 |
| 5 | GENDER RELATED DIFFERENCES | 4 | 10% | 5% | 35 |
| 6 | CARDIOMYOCYTE CA2 | 3 | 100% | 0% | 3 |
| 7 | NON GENOMIC ACTION | 3 | 60% | 0% | 3 |
| 8 | ACUTE ISCHEMIA REPERFUSION | 2 | 67% | 0% | 2 |
| 9 | CARDIAC REMODELING SECONDARY | 2 | 67% | 0% | 2 |
| 10 | FEMALE HEARTS | 2 | 67% | 0% | 2 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Sex differences in mechanisms of cardiac excitation-contraction coupling | 2013 | 14 | 114 | 54% |
| Sex and sex hormones in cardiac stress-Mechanistic insights | 2013 | 9 | 157 | 62% |
| Gender Differences in Cardiac Ischemic Injury and Protection-Experimental Aspects | 2009 | 35 | 64 | 63% |
| Gender disparity in cardiac electrophysiology: Implications for cardiac safety pharmacology | 2010 | 29 | 73 | 62% |
| Sex-based differences in cardiac ischaemic injury and protection: therapeutic implications | 2014 | 3 | 128 | 43% |
| Estrogen and the cardiovascular system | 2012 | 49 | 194 | 18% |
| Gender-based differences in mechanisms of protection in myocardial ischemia-reperfusion injury | 2007 | 98 | 80 | 34% |
| Sex Hormones and the QT Interval: A Review | 2012 | 7 | 34 | 71% |
| Estrogen Receptor Activation and Cardioprotection in Ischemia Reperfusion Injury | 2010 | 29 | 37 | 49% |
| Sex Differences in Cardiac Electrophysiology and Clinical Arrhythmias: Epidemiology, Therapeutics, and Mechanisms | 2014 | 3 | 101 | 36% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PARTNERSHIP WOMENS HLTH | 4 | 75% | 0.4% | 3 |
| 2 | NOLL 106 | 4 | 56% | 0.7% | 5 |
| 3 | CARDIAC PHEN | 3 | 50% | 0.7% | 5 |
| 4 | GENDER MED | 2 | 10% | 2.5% | 19 |
| 5 | BIOINFORMAT PHARMACOL | 2 | 22% | 1.1% | 8 |
| 6 | INBB OSILO SASSARI | 1 | 100% | 0.3% | 2 |
| 7 | MED POLIKLIN 2 | 1 | 50% | 0.3% | 2 |
| 8 | GENDER MED GIM | 1 | 40% | 0.3% | 2 |
| 9 | CARDIOVASC SCI ABORAT PROGRAM | 1 | 25% | 0.4% | 3 |
| 10 | IGDP PHYSIOL | 1 | 33% | 0.3% | 2 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000133247 | HORMONE REPLACEMENT THERAPY//HORMONE THERAPY//TIMING HYPOTHESIS |
| 2 | 0.0000118477 | SPONTANEOUS PROTEINURIA//STUDY SEX DIFFERENCES HLTH AGING DIS//SEX GENDER DIFFERENCES HLTH DIS |
| 3 | 0.0000098827 | QT DISPERSION//QT INTERVAL//THOROUGH QT STUDY |
| 4 | 0.0000094593 | AVITRIPTAN//ENVIRONM INJURY EPIDEMIOL TOXICOL UNIT//HOMICIDE PREVENTION |
| 5 | 0.0000093356 | TORSADES DE POINTES//TORSADE DE POINTES//ELECT ENGN CYBERNET |
| 6 | 0.0000089766 | GPR30//GPER//PELP1 |
| 7 | 0.0000080632 | FEMALE GENDER//EMORY PROGRAM CARDIOVASC OUTCOMES EPIDEMIOL//LILLEHAMMER |
| 8 | 0.0000068689 | BIODINAM MOVIMENTO CORPO HUMANO//SPORTS ANAT//EXERCISE PRECONDITIONING |
| 9 | 0.0000068492 | CORONARY ARTERY NARROWING//VENTRICULAR FAILURE//BALKE BIODYNAM |
| 10 | 0.0000067960 | TRAUMA HEMORRHAGE//IMMUNE DEPRESSION//INVIVO HEMOREFLECTOMETER |